Senseonics to Participate in the H.C. Wainwright Global Investment ConferenceBusiness Wire • 05/16/22
Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/11/22
Senseonics Holdings, Inc. Schedules First Quarter 2022 Earnings Release and Conference Call for May 10, 2022, at 4:30 p.m. Eastern TimeBusiness Wire • 04/26/22
Senseonics Announces the First Patient Implant of the Eversense E3 CGM System in the U.S.Business Wire • 04/06/22
Senseonics Holdings (SENS) Beats Q4 Earnings and Revenue EstimatesZacks Investment Research • 03/02/22
Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/02/22
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Financial ResultsBusiness Wire • 03/01/22
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call for March 1, 2022, at 4:30 p.m. Eastern TimeBusiness Wire • 02/15/22
ASCENSIA DIABETES CARE ANNOUNCES FDA APPROVAL OF THE EVERSENSE E3 CONTINUOUS GLUCOSE MONITORING SYSTEM FOR USE FOR UP TO 6 MONTHSPRNewsWire • 02/14/22
Senseonics Announces FDA Approval of the Eversense® E3 Continuous Glucose Monitoring System for Use for Up to 6 months; Provides 2022 Business OutlookBusiness Wire • 02/11/22